M. di Pietro

发表

Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.

A. d’Arminio Monforte, F. Baldanti, F. Ceccherini‐Silberstein, 2012, The new microbiologica.

Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group.

F. Baldanti, F. Ceccherini‐Silberstein, R. Maserati, 2010, The new microbiologica.

Predictors of poor outcome in tocilizumab treated patients with Sars-CoV-2 related severe respiratory failure: A multicentre real world study

P. Lotti, A. Faraone, G. Landini, 2022, International Immunopharmacology.

Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: a MASTER cohort study.

F. Donato, F. Castelli, A. Gori, 2016, The Journal of antimicrobial chemotherapy.

Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study

D. Podzamczer, B. Clotet, A. Winston, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial

A. Lazzarin, O. Picconi, M. Magnani, 2015, Retrovirology.

Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry.

Matthew Banks, Ian Penman, Jason Dunn, 2013, World journal of gastroenterology.

Cataracts in three children with a newly recognised neurocutaneous malformation phenotype with “cutis tricolor”

A. Polizzi, G. Magro, M. Ruggieri, 2008, British Journal of Ophthalmology.

Antimicrobial stewardship in an Internal Medicine ward: effects on antibiotic consumption and on the use of carbapenems

A. Faraone, M. di Pietro, A. Fortini, 2018, Internal and Emergency Medicine.

Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART

L. Chatenoud, F. Castelli, A. Gori, 2015, PloS one.

Comparing outcome of radiofrequency ablation in Barrett’s with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry

R. Haidry, L. Lovat, R. Sweis, 2015, Endoscopy.

Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)

G. d’Ettorre, N. Ciccarelli, A. Antinori, 2017, The Journal of antimicrobial chemotherapy.

Maraviroc 150 mg daily plus lopinavir/ritonavir, a nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimen for HIV-infected naive patients: 48-week final results of VEMAN study.

A. Lazzarin, A. Antinori, F. Mazzotta, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Exploratory Analysis for the Evaluation of Estimated Glomerular Filtration Rate, Cholesterol and Triglycerides after Switching from Tenofovir/Emtricitabine plus Atazanavir/Ritonavir (ATV/r) to Abacavir/Lamivudine plus ATV/r in Patients with Preserved Renal Function

S. Di Giambenedetto, C. Torti, E. Quiros-Roldan, 2016, The open AIDS journal.

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience

M. Benucci, M. Infantino, V. Grossi, 2022, Clinical Immunology.

Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies

A. Polizzi, A. Chiarenza, M. Ruggieri, 2016, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.